調査レポート | • レポートコード：GIR-2104Z12685 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、皮膚がん診断のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。皮膚がん診断の種類別市場規模（基底細胞がん、扁平上皮がん、悪性黒色腫、その他）、用途別市場規模（病院、診療所、研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・皮膚がん診断の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Alma Lasers、Agilent Technologies Inc、Biolitec Ag、Bruker Corp、Ellipse A/S、GE Healthcare、Leica Microsystems、Michelson Diagnostics、Syneron Medical、Canon Medical Systems ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：基底細胞がん、扁平上皮がん、悪性黒色腫、その他 ・用途別分析2016年-2026年：病院、診療所、研究所、その他 ・皮膚がん診断の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・皮膚がん診断のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・皮膚がん診断のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・皮膚がん診断の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・皮膚がん診断の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Skin Cancer Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Skin Cancer Diagnostics size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Skin Cancer Diagnostics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Skin Cancer Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Basal Cell Carcinoma
Squamous Cell Carcinoma
Malignant Melanoma
Others
Market segment by Application, can be divided into
Hospital
Clinic
Laboratory
Others
Market segment by players, this report covers
Alma Lasers
Agilent Technologies Inc
Biolitec Ag
Bruker Corp
Ellipse A/S
GE Healthcare
Leica Microsystems
Michelson Diagnostics
Syneron Medical
Canon Medical Systems
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Skin Cancer Diagnostics
1.2 Classification of Skin Cancer Diagnostics by Type
1.2.1 Overview: Global Skin Cancer Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Skin Cancer Diagnostics Revenue Market Share by Type in 2020
1.2.3 Basal Cell Carcinoma
1.2.4 Squamous Cell Carcinoma
1.2.5 Malignant Melanoma
1.2.6 Others
1.3 Global Skin Cancer Diagnostics Market by Application
1.3.1 Overview: Global Skin Cancer Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Laboratory
1.3.5 Others
1.4 Global Skin Cancer Diagnostics Market Size & Forecast
1.5 Global Skin Cancer Diagnostics Market Size and Forecast by Region
1.5.1 Global Skin Cancer Diagnostics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Skin Cancer Diagnostics Market Size by Region, (2016-2021)
1.5.3 North America Skin Cancer Diagnostics Market Size and Prospect (2016-2026)
1.5.4 Europe Skin Cancer Diagnostics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Skin Cancer Diagnostics Market Size and Prospect (2016-2026)
1.5.6 South America Skin Cancer Diagnostics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Skin Cancer Diagnostics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Skin Cancer Diagnostics Market Drivers
1.6.2 Skin Cancer Diagnostics Market Restraints
1.6.3 Skin Cancer Diagnostics Trends Analysis
2 Company Profiles
2.1 Alma Lasers
2.1.1 Alma Lasers Details
2.1.2 Alma Lasers Major Business
2.1.3 Alma Lasers Skin Cancer Diagnostics Product and Solutions
2.1.4 Alma Lasers Skin Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Alma Lasers Recent Developments and Future Plans
2.2 Agilent Technologies Inc
2.2.1 Agilent Technologies Inc Details
2.2.2 Agilent Technologies Inc Major Business
2.2.3 Agilent Technologies Inc Skin Cancer Diagnostics Product and Solutions
2.2.4 Agilent Technologies Inc Skin Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Agilent Technologies Inc Recent Developments and Future Plans
2.3 Biolitec Ag
2.3.1 Biolitec Ag Details
2.3.2 Biolitec Ag Major Business
2.3.3 Biolitec Ag Skin Cancer Diagnostics Product and Solutions
2.3.4 Biolitec Ag Skin Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Biolitec Ag Recent Developments and Future Plans
2.4 Bruker Corp
2.4.1 Bruker Corp Details
2.4.2 Bruker Corp Major Business
2.4.3 Bruker Corp Skin Cancer Diagnostics Product and Solutions
2.4.4 Bruker Corp Skin Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Bruker Corp Recent Developments and Future Plans
2.5 Ellipse A/S
2.5.1 Ellipse A/S Details
2.5.2 Ellipse A/S Major Business
2.5.3 Ellipse A/S Skin Cancer Diagnostics Product and Solutions
2.5.4 Ellipse A/S Skin Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Ellipse A/S Recent Developments and Future Plans
2.6 GE Healthcare
2.6.1 GE Healthcare Details
2.6.2 GE Healthcare Major Business
2.6.3 GE Healthcare Skin Cancer Diagnostics Product and Solutions
2.6.4 GE Healthcare Skin Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 GE Healthcare Recent Developments and Future Plans
2.7 Leica Microsystems
2.7.1 Leica Microsystems Details
2.7.2 Leica Microsystems Major Business
2.7.3 Leica Microsystems Skin Cancer Diagnostics Product and Solutions
2.7.4 Leica Microsystems Skin Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Leica Microsystems Recent Developments and Future Plans
2.8 Michelson Diagnostics
2.8.1 Michelson Diagnostics Details
2.8.2 Michelson Diagnostics Major Business
2.8.3 Michelson Diagnostics Skin Cancer Diagnostics Product and Solutions
2.8.4 Michelson Diagnostics Skin Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Michelson Diagnostics Recent Developments and Future Plans
2.9 Syneron Medical
2.9.1 Syneron Medical Details
2.9.2 Syneron Medical Major Business
2.9.3 Syneron Medical Skin Cancer Diagnostics Product and Solutions
2.9.4 Syneron Medical Skin Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Syneron Medical Recent Developments and Future Plans
2.10 Canon Medical Systems
2.10.1 Canon Medical Systems Details
2.10.2 Canon Medical Systems Major Business
2.10.3 Canon Medical Systems Skin Cancer Diagnostics Product and Solutions
2.10.4 Canon Medical Systems Skin Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Canon Medical Systems Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Skin Cancer Diagnostics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Skin Cancer Diagnostics Players Market Share
3.2.2 Top 10 Skin Cancer Diagnostics Players Market Share
3.2.3 Market Competition Trend
3.3 Skin Cancer Diagnostics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Skin Cancer Diagnostics Revenue and Market Share by Type (2016-2021)
4.2 Global Skin Cancer Diagnostics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Skin Cancer Diagnostics Revenue Market Share by Application (2016-2021)
5.2 Skin Cancer Diagnostics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Skin Cancer Diagnostics Revenue by Type (2016-2026)
6.2 North America Skin Cancer Diagnostics Revenue by Application (2016-2026)
6.3 North America Skin Cancer Diagnostics Market Size by Country
6.3.1 North America Skin Cancer Diagnostics Revenue by Country (2016-2026)
6.3.2 United States Skin Cancer Diagnostics Market Size and Forecast (2016-2026)
6.3.3 Canada Skin Cancer Diagnostics Market Size and Forecast (2016-2026)
6.3.4 Mexico Skin Cancer Diagnostics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Skin Cancer Diagnostics Revenue by Type (2016-2026)
7.2 Europe Skin Cancer Diagnostics Revenue by Application (2016-2026)
7.3 Europe Skin Cancer Diagnostics Market Size by Country
7.3.1 Europe Skin Cancer Diagnostics Revenue by Country (2016-2026)
7.3.2 Germany Skin Cancer Diagnostics Market Size and Forecast (2016-2026)
7.3.3 France Skin Cancer Diagnostics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Skin Cancer Diagnostics Market Size and Forecast (2016-2026)
7.3.5 Russia Skin Cancer Diagnostics Market Size and Forecast (2016-2026)
7.3.6 Italy Skin Cancer Diagnostics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Skin Cancer Diagnostics Revenue by Type (2016-2026)
8.2 Asia-Pacific Skin Cancer Diagnostics Revenue by Application (2016-2026)
8.3 Asia-Pacific Skin Cancer Diagnostics Market Size by Region
8.3.1 Asia-Pacific Skin Cancer Diagnostics Revenue by Region (2016-2026)
8.3.2 China Skin Cancer Diagnostics Market Size and Forecast (2016-2026)
8.3.3 Japan Skin Cancer Diagnostics Market Size and Forecast (2016-2026)
8.3.4 South Korea Skin Cancer Diagnostics Market Size and Forecast (2016-2026)
8.3.5 India Skin Cancer Diagnostics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Skin Cancer Diagnostics Market Size and Forecast (2016-2026)
8.3.7 Australia Skin Cancer Diagnostics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Skin Cancer Diagnostics Revenue by Type (2016-2026)
9.2 South America Skin Cancer Diagnostics Revenue by Application (2016-2026)
9.3 South America Skin Cancer Diagnostics Market Size by Country
9.3.1 South America Skin Cancer Diagnostics Revenue by Country (2016-2026)
9.3.2 Brazil Skin Cancer Diagnostics Market Size and Forecast (2016-2026)
9.3.3 Argentina Skin Cancer Diagnostics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Skin Cancer Diagnostics Revenue by Type (2016-2026)
10.2 Middle East & Africa Skin Cancer Diagnostics Revenue by Application (2016-2026)
10.3 Middle East & Africa Skin Cancer Diagnostics Market Size by Country
10.3.1 Middle East & Africa Skin Cancer Diagnostics Revenue by Country (2016-2026)
10.3.2 Turkey Skin Cancer Diagnostics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Skin Cancer Diagnostics Market Size and Forecast (2016-2026)
10.3.4 UAE Skin Cancer Diagnostics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Skin Cancer Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Skin Cancer Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Skin Cancer Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Skin Cancer Diagnostics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Skin Cancer Diagnostics Revenue Market Share by Region (2021-2026)
Table 6. Alma Lasers Corporate Information, Head Office, and Major Competitors
Table 7. Alma Lasers Major Business
Table 8. Alma Lasers Skin Cancer Diagnostics Product and Solutions
Table 9. Alma Lasers Skin Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Agilent Technologies Inc Corporate Information, Head Office, and Major Competitors
Table 11. Agilent Technologies Inc Major Business
Table 12. Agilent Technologies Inc Skin Cancer Diagnostics Product and Solutions
Table 13. Agilent Technologies Inc Skin Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Biolitec Ag Corporate Information, Head Office, and Major Competitors
Table 15. Biolitec Ag Major Business
Table 16. Biolitec Ag Skin Cancer Diagnostics Product and Solutions
Table 17. Biolitec Ag Skin Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Bruker Corp Corporate Information, Head Office, and Major Competitors
Table 19. Bruker Corp Major Business
Table 20. Bruker Corp Skin Cancer Diagnostics Product and Solutions
Table 21. Bruker Corp Skin Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Ellipse A/S Corporate Information, Head Office, and Major Competitors
Table 23. Ellipse A/S Major Business
Table 24. Ellipse A/S Skin Cancer Diagnostics Product and Solutions
Table 25. Ellipse A/S Skin Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. GE Healthcare Corporate Information, Head Office, and Major Competitors
Table 27. GE Healthcare Major Business
Table 28. GE Healthcare Skin Cancer Diagnostics Product and Solutions
Table 29. GE Healthcare Skin Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Leica Microsystems Corporate Information, Head Office, and Major Competitors
Table 31. Leica Microsystems Major Business
Table 32. Leica Microsystems Skin Cancer Diagnostics Product and Solutions
Table 33. Leica Microsystems Skin Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Michelson Diagnostics Corporate Information, Head Office, and Major Competitors
Table 35. Michelson Diagnostics Major Business
Table 36. Michelson Diagnostics Skin Cancer Diagnostics Product and Solutions
Table 37. Michelson Diagnostics Skin Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Syneron Medical Corporate Information, Head Office, and Major Competitors
Table 39. Syneron Medical Major Business
Table 40. Syneron Medical Skin Cancer Diagnostics Product and Solutions
Table 41. Syneron Medical Skin Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Canon Medical Systems Corporate Information, Head Office, and Major Competitors
Table 43. Canon Medical Systems Major Business
Table 44. Canon Medical Systems Skin Cancer Diagnostics Product and Solutions
Table 45. Canon Medical Systems Skin Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Skin Cancer Diagnostics Revenue (USD Million) by Players (2019-2021)
Table 47. Global Skin Cancer Diagnostics Revenue Share by Players (2019-2021)
Table 48. Breakdown of Skin Cancer Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Skin Cancer Diagnostics Players Head Office, Products and Services Provided
Table 50. Skin Cancer Diagnostics Mergers & Acquisitions in the Past Five Years
Table 51. Skin Cancer Diagnostics New Entrants and Expansion Plans
Table 52. Global Skin Cancer Diagnostics Revenue (USD Million) by Type (2016-2021)
Table 53. Global Skin Cancer Diagnostics Revenue Share by Type (2016-2021)
Table 54. Global Skin Cancer Diagnostics Revenue Forecast by Type (2021-2026)
Table 55. Global Skin Cancer Diagnostics Revenue by Application (2016-2021)
Table 56. Global Skin Cancer Diagnostics Revenue Forecast by Application (2021-2026)
Table 57. North America Skin Cancer Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Skin Cancer Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Skin Cancer Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Skin Cancer Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Skin Cancer Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Skin Cancer Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Skin Cancer Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Skin Cancer Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Skin Cancer Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Skin Cancer Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Skin Cancer Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Skin Cancer Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Skin Cancer Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Skin Cancer Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Skin Cancer Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Skin Cancer Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Skin Cancer Diagnostics Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Skin Cancer Diagnostics Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Skin Cancer Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Skin Cancer Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Skin Cancer Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Skin Cancer Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Skin Cancer Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Skin Cancer Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Skin Cancer Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Skin Cancer Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Skin Cancer Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Skin Cancer Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Skin Cancer Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Skin Cancer Diagnostics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Skin Cancer Diagnostics Picture
Figure 2. Global Skin Cancer Diagnostics Revenue Market Share by Type in 2020
Figure 3. Basal Cell Carcinoma
Figure 4. Squamous Cell Carcinoma
Figure 5. Malignant Melanoma
Figure 6. Others
Figure 7. Skin Cancer Diagnostics Revenue Market Share by Application in 2020
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Laboratory Picture
Figure 11. Others Picture
Figure 12. Global Skin Cancer Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Skin Cancer Diagnostics Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Skin Cancer Diagnostics Revenue Market Share by Region (2016-2026)
Figure 15. Global Skin Cancer Diagnostics Revenue Market Share by Region in 2020
Figure 16. North America Skin Cancer Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Skin Cancer Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Skin Cancer Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Skin Cancer Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Skin Cancer Diagnostics Market Drivers
Figure 21. Skin Cancer Diagnostics Market Restraints
Figure 22. Skin Cancer Diagnostics Market Trends
Figure 23. Alma Lasers Recent Developments and Future Plans
Figure 24. Agilent Technologies Inc Recent Developments and Future Plans
Figure 25. Biolitec Ag Recent Developments and Future Plans
Figure 26. Bruker Corp Recent Developments and Future Plans
Figure 27. Ellipse A/S Recent Developments and Future Plans
Figure 28. GE Healthcare Recent Developments and Future Plans
Figure 29. Leica Microsystems Recent Developments and Future Plans
Figure 30. Michelson Diagnostics Recent Developments and Future Plans
Figure 31. Syneron Medical Recent Developments and Future Plans
Figure 32. Canon Medical Systems Recent Developments and Future Plans
Figure 34. Global Skin Cancer Diagnostics Revenue Share by Players in 2020
Figure 35. Skin Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players Skin Cancer Diagnostics Revenue Market Share in 2020
Figure 37. Global Top 10 Players Skin Cancer Diagnostics Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global Skin Cancer Diagnostics Revenue Share by Type in 2020
Figure 40. Global Skin Cancer Diagnostics Market Share Forecast by Type (2021-2026)
Figure 41. Global Skin Cancer Diagnostics Revenue Share by Application in 2020
Figure 42. Global Skin Cancer Diagnostics Market Share Forecast by Application (2021-2026)
Figure 43. North America Skin Cancer Diagnostics Sales Market Share by Type (2016-2026)
Figure 44. North America Skin Cancer Diagnostics Sales Market Share by Application (2016-2026)
Figure 45. North America Skin Cancer Diagnostics Revenue Market Share by Country (2016-2026)
Figure 46. United States Skin Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Skin Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Skin Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Skin Cancer Diagnostics Sales Market Share by Type (2016-2026)
Figure 50. Europe Skin Cancer Diagnostics Sales Market Share by Application (2016-2026)
Figure 51. Europe Skin Cancer Diagnostics Revenue Market Share by Country (2016-2026)
Figure 52. Germany Skin Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Skin Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Skin Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Skin Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Skin Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Skin Cancer Diagnostics Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific Skin Cancer Diagnostics Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Skin Cancer Diagnostics Revenue Market Share by Region (2016-2026)
Figure 60. China Skin Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Skin Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea Skin Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Skin Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Skin Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Skin Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Skin Cancer Diagnostics Sales Market Share by Type (2016-2026)
Figure 67. South America Skin Cancer Diagnostics Sales Market Share by Application (2016-2026)
Figure 68. South America Skin Cancer Diagnostics Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Skin Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Skin Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa Skin Cancer Diagnostics Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa Skin Cancer Diagnostics Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa Skin Cancer Diagnostics Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Skin Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Skin Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE Skin Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の皮膚がん診断＆治療市場規模・現状・予測（2021年-2027年） On the basis of the type of tissue affected, there are three major types of skin cancer, namely, basal cell carcinoma, squamous-cell carcinoma, and melanoma. Factors such as increasing incidences of skin cancer, favorable government initiatives, the development of novel immunotherapies, and the exte…- 世界の基底細胞皮膚がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Basal Cell Skin Cancer Treatment Market The global Basal Cell Skin Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
- 世界の基底細胞皮膚がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Basal Cell Skin Cancer Treatment Market The global Basal Cell Skin Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
- 世界の皮膚ガン市場規模・現状・予測（2021年-2027年） Skin cancer is the most common type of cancer, which arise due to uncontrolled growth of abnormal skin cells. It occurs when skin cells are damaged by unrepaired DNA or genetic defects that lead the uncontrolled growth of cells in the skin. Market Analysis and Insights: Global Skin Cancer Market The…
- 世界の非黒色腫皮膚がん市場規模・現状・予測（2021年-2027年） Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlike…